| 000 | 01865 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513191043.0 | ||
| 264 | 0 | _c19990823 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/s0959-8049(98)00397-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHausmaninger, H | |
| 245 | 0 | 0 |
_aBiochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: final results of a randomised phase III study. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cMar 1999 |
||
| 300 |
_a380-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon Type I _xadministration & dosage |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMoser, R | |
| 700 | 1 | _aSamonigg, H | |
| 700 | 1 | _aMlineritsch, B | |
| 700 | 1 | _aSchmidt, H | |
| 700 | 1 | _aPecherstorfer, M | |
| 700 | 1 | _aFridrik, M | |
| 700 | 1 | _aKopf, C | |
| 700 | 1 | _aNitsche, D | |
| 700 | 1 | _aKaider, A | |
| 700 | 1 | _aLudwig, H | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 35 _gno. 3 _gp. 380-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0959-8049(98)00397-9 _zAvailable from publisher's website |
| 999 |
_c10406005 _d10406005 |
||